Invention Grant
- Patent Title: Acyl sulfonamide NaV1.7 inhibitors
-
Application No.: US16092075Application Date: 2017-04-19
-
Publication No.: US10550080B2Publication Date: 2020-02-04
- Inventor: Guanglin Luo , Ling Chen
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2017/028217 WO 20170419
- International Announcement: WO2017/184658 WO 20171026
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/416 ; C07D209/32 ; C07D231/56 ; C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D409/12 ; A61P25/04
Abstract:
The present disclosure relates to compounds of formula I which inhibit NaV1.7, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions.
Public/Granted literature
- US20190119209A1 ACYL SULFONAMIDE NaV1.7 INHIBITORS Public/Granted day:2019-04-25
Information query
IPC分类:
